The buyback continues at a steady pace with no acceleration or deceleration signaled. Monitor for any change in program size or completion timeline, but no immediate trading catalyst.
Price Chart
Executive Summary
Novo Nordisk reported weekly share repurchase transactions under its ongoing DKK 15 billion buyback program. Through 17 July 2026, the company has repurchased 24.96 million B shares for DKK 6.85 billion, representing 0.9% of share capital. The update is routine with no change in program terms or pace.
Key Facts
- Overall buyback program of up to DKK 15 billion over 12 months from 4 Feb 2026
- Sub-program of up to DKK 11.2 billion runs 6 May 2026 to 1 Feb 2027
- Weekly transactions (13-17 Jul): 975,000 B shares repurchased for ~DKK 318.6 million
- Cumulative under sub-program: 10.2 million shares for DKK 3.05 billion
- Total repurchased since 4 Feb: 24,959,179 B shares at avg DKK 274.58, value DKK 6.85 billion
- Treasury shares now 42,144,480 B shares = 0.9% of share capital
Financial Impact
Routine buyback update; no new financial data provided. Total deployed so far DKK 6.85 billion (~$1B equivalent at current rates, but exact USD not disclosed).
Risk Factors
- No material risks identified from this routine update
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-004788 |
| Document: 0001171843-26-004788-index-headers.html | 0001171843-26-004788 |
| Document: 0001171843-26-004788-index.html | 0001171843-26-004788 |
| Document: 0001171843-26-004788.txt | 0001171843-26-004788 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 7d ago | 6-K | $39.13 | awaiting T+20 | awaiting T+20 | $40.45 (+3.37%) |
Oct 26, 2026 8d ago | Court Ruling | $38.67 | awaiting T+20 | awaiting T+20 | $40.45 (+4.60%) |
Oct 19, 2026 14d ago | 6-K | $38.42 | awaiting T+20 | awaiting T+20 | $40.45 (+5.28%) |
Oct 13, 2026 20d ago | 6-K | $38.06 | awaiting T+20 | awaiting T+20 | $40.45 (+6.28%) |
Oct 6, 2026 27d ago | 6-K | $37.53 | awaiting T+20 | awaiting T+20 | $40.45 (+7.78%) |
Sep 28, 2026 5w ago | 6-K | $38.71 $38.95 | ▲ +0.61% | ▲ +0.64% | $40.45 (+4.49%) |
Sep 23, 2026 5w ago | Court Ruling | $38.62 $39.43 | ▲ +2.10% | ▲ +2.52% | $40.45 (+4.74%) |
Sep 21, 2026 6w ago | 6-K | $39.80 $38.42 | ▼ −3.47% | ▼ −2.56% | $40.45 (+1.63%) |
Sep 17, 2026 6w ago | 6-K | $43.19 $39.22 | ▼ −9.19% | ▼ −10.40% | $40.45 (−6.34%) |
Sep 15, 2026 6w ago | 6-K | $42.53 $38.06 | ▼ −10.51% | ▼ −13.23% | $40.45 (−4.89%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers